Multiple study locations (see Central Contact); CV Therapeutics, Inc. is a clinical research site located in Palo Alto, California, United States 94304.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Multiple study locations (see Central Contact); CV Therapeutics, Inc. has participated in 2 clinical trials.
Therapeutic areas: Coronary Artery Disease.
Sponsors: Gilead Sciences.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Multiple study locations (see Central Contact); CV Therapeutics, Inc. has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Multiple study locations (see Central Contact); CV Therapeutics, Inc. has 2 clinical trials on record. Their work covers Coronary Artery Disease.
Multiple study locations (see Central Contact); CV Therapeutics, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.